FDA Drug recall D-439-2013
Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe…
- FDA Drug
- Class II
- terminated
- Published 2013-05-29
On 2013-05-29 the FDA classified a Class II recall of Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the labe… by Lloyd, citing cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-439-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-04-01 |
| Published | 2013-05-29 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Lloyd |
| Distribution | US |
Product
Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Reason
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Identifiers
| code_info | Lot #: HE27211, Exp Apr-13; HE35511, Exp Jul-13; HA04112, Exp Aug-13; HC06212, Exp Sep-12. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-439-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.